Abstract P9 Table 1

Demographic, laboratory and clinical characteristics of patients

Total population (n=98)
n (%)
PAPS (n =42)
n (%)
SLE/APS (n =56)
n (%)
P
Female 83 (84.7) 36 (85.7) 47 (83.9) 0.52
Age, years (mean ± SD ) 42.4 (10.9) 44.6 (11.6) 40.8 (10.1) 0.42
Disease duration, years (mean ± SD ) 9.8 (7.8) 10 (8.8) 9.7 (7.1) 0.16
Thrombosis
Arterial
Venous
Recurrent
 o A→V
 o V→A
 o A→A
 o V→V
87 (88.8)
58 (66.7)
45 (51.7)
37 (42.5)
3 (8.1)
15 (40.5)
9 (24.3)
10 (27)
35 (83.3)
24 (68.6)
19 (54.3)
15 (42.9)
2 (13.3)
6 (40)
2 (13.3)
5 (33.3)
52 (92.9)
34 (65.4)
26 (50)
22 (42.3)
1 (4.5)
9 (40.9)
7 (31.8)
5 (22.7)
0.12
0.47
0.43
0.56
Pregnancy morbidity
< 10 weeks , ≥ 3 abortions
10 weeks , ≥ 1 abortion
Pre-eclampsia/eclampsia
< 34 weeks , ≥ 1 premature birth
40 (40.8)
9 (22.5)
29 (72.5)
8 (20)
6 (15)
20 (47.6)
5 (25)
14 (70)
3 (15)
1 (5)
20 (35.7)
4 (20)
15 (75)
5 (25)
5 (25)
0.16
0.5
0.5
0.34
0.09
Livedo reticularis 11 (11.2) 2 (4.8) 9 (16.1) 0.07
Thrombocytopenia 33 (33.7) 9 (21.4) 24 (42.9) 0.02
APS nephropathy 9 (9.2) 2 (4.8) 7 (12.5) 0.17
Valvular heart disease 33 (33.7) 12 (28.6) 21 (37.5) 0.24
Conventional risk factors
 • Arterial hypertension
 • Hyperlipidemia
 • Diabetes mellitus
 • Obesity
 • Smoking
53 (53.1)
47 (48)
6 (6.1)
35 (35.7)
30 (30.6)
17 (40.5)
21 (50)
3 (7.1)
19 (45.2)
12 (28.6)
35 (62.5)
26 (46.4)
3 (5.4)
16 (28.6)
18 (32.1)
0.02
0.41
0.51
0.07
0.43
aPL profile
 • LA
 • aCL IgG/IgM
 • aβ2GPI IgG/IgM
 • Triple positive
77 (78.6)
59 (60.2)
49 (50)
30 (30.6)
29 (69)
31 (73.8)
22 (56.4)
14 (33.3)
48 (85.7)
28 (52.8)
27 (52.9)
17 (30.4)
0.04
0.03
0.45
0.46